Results 261 to 270 of about 93,843 (327)
Some of the next articles are maybe not open access.
Journal of Viral Hepatitis, 2019
The correlation between serum HBcrAg and HBV RNA is unclear, and correlations of intrahepatic cccDNA with HBcrAg, HBV RNA and HBsAg are rarely reported in the same cohort.
E. Chen+6 more
semanticscholar +1 more source
The correlation between serum HBcrAg and HBV RNA is unclear, and correlations of intrahepatic cccDNA with HBcrAg, HBV RNA and HBsAg are rarely reported in the same cohort.
E. Chen+6 more
semanticscholar +1 more source
Polypeptide composition of HBsag
Archives of Virology, 1977Purified HBsag has a complex structure comprising 8 polypeptides. Some of these polypeptides are immunogenic and induce both humoral and cell-mediated immunity in guinea pigs.
M. Teoharova+3 more
openaire +3 more sources
Transplant Infectious Disease, 2016
AbstractAimThe aim of this study was to determine the effects of hepatitis B surface antigen (HBsAg) positivity of the donors on graft survival and liver complications in HBsAg(+) renal transplant recipients.Patients and methodA group of 55 patients who underwent renal transplantation (RTx) in our hospital between 2001 and 2012 were included in the ...
Huseyin Kocak+6 more
openaire +3 more sources
AbstractAimThe aim of this study was to determine the effects of hepatitis B surface antigen (HBsAg) positivity of the donors on graft survival and liver complications in HBsAg(+) renal transplant recipients.Patients and methodA group of 55 patients who underwent renal transplantation (RTx) in our hospital between 2001 and 2012 were included in the ...
Huseyin Kocak+6 more
openaire +3 more sources
DETECTION OF HBsAg IN THE PANCREAS
Acta Pathologica Japonica, 1981Hepatitis B surface antigen (HBsAg) has been reported to be present in other organs than the liver.3,9 So far as our knowledge is concerned, however, any report of cases dealing with pancreatic diseases induced by hepatitis B virus (HBV) has not been described in the English and Japanese literature.
Isamu Sakurai+5 more
openaire +3 more sources
Presence of HBsAg in the Bile of Subjects with Acute HBsAg Viral Hepatitis
Pathobiology, 1975During acute HB<sub>s</sub>Ag serum positive viral hepatitis, the surface antigen was not detectable in duodenal bile but was almost always present in gallbladder and hepatic bile when cholecystokinin was intravenously administered. The immunologic nondemonstrability of HB<sub>s</sub>Ag in duodenal bile is probably due to the ...
L. Cacciatore+8 more
openaire +3 more sources
Journal of Viral Hepatitis, 2019
Cessation of nucleos(t)ide analogue (Nuc) therapy in HBeAg‐negative patients may increase HBsAg loss rate in patients with sustained remission (SR) and non‐retreated clinical relapsers (CR).
W. Jeng, Ming-Ling Chang, Y. Liaw
semanticscholar +1 more source
Cessation of nucleos(t)ide analogue (Nuc) therapy in HBeAg‐negative patients may increase HBsAg loss rate in patients with sustained remission (SR) and non‐retreated clinical relapsers (CR).
W. Jeng, Ming-Ling Chang, Y. Liaw
semanticscholar +1 more source
Quantitative Determination of the HBsAg
Vox Sanguinis, 1980Abstract. HBsAg concentrations down to 0.05 mg/ml can be measured by a quantitative immunoelectrophoresis. By a quantitative radioimmunoassay, HBsAg concentrations from 0.001 mg to 1 mg/ml can be measured.
openaire +3 more sources
Circulating HBsAg/IgM complexes in chronic HBsAg carriers
Annales de l'Institut Pasteur / Virologie, 1983Summary Sera of young male HBsAg carriers from Senegal were investigated for complexes between IgM and HBsAg. An enzyme-linked immunosorbent assay based on selective absorption of IgM was used. HBsAg/IgM complexes were detected in 14% of the HBsAg carriers.
J.L. Barres+7 more
openaire +2 more sources
Calibration of qualitative HBsAg assay results for quantitative HBsAg monitoring
Journal of Clinical Virology, 2014Evidence is accumulating that quantitative hepatitis B surface antigen monitoring may be useful in managing patients with chronic HBV infection on certain treatment regimens. Based on these results with the Abbott Architect qualitative and quantitative HBsAg assays, it seems feasible to convert qualitative to quantitative HBsAg values for this purpose.
Julian W. Tang+2 more
openaire +3 more sources
Diagnostic Microbiology and Infectious Disease, 2011
A low initial reactive rate for screening assays is important for time- and cost-effective infectious disease testing. Therefore, the new ARCHITECT HBsAg Qualitative screening assay, in conjunction with the new ARCHITECT HBsAg Qualitative Confirmatory assay, was introduced.
Christian Beckert+8 more
openaire +3 more sources
A low initial reactive rate for screening assays is important for time- and cost-effective infectious disease testing. Therefore, the new ARCHITECT HBsAg Qualitative screening assay, in conjunction with the new ARCHITECT HBsAg Qualitative Confirmatory assay, was introduced.
Christian Beckert+8 more
openaire +3 more sources